Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.
Choo R, Corbin K, Merrell K, Stish B, Pisansky TM, Davis BJ, Amundson A, Hillman DW, Mitchell C, Wong W, Vargas C, Rwigema JC, Keole S, Vora S, Daniels T.
Choo R, et al. Among authors: amundson a.
Int J Radiat Oncol Biol Phys. 2024 Dec 11:S0360-3016(24)03722-2. doi: 10.1016/j.ijrobp.2024.11.115. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39672515